Abstract
More than 50 % of untreated patients with celiac disease (CD) have bone loss detected by bone densitometry (dual-energy X-ray absorptiometry:DXA). Moreover, patients with CD are more likely to have osteoporosis and fragility fractures, especially of the distal radius. Although still controversial, we recommend DXA screening in all celiac disease patients, particularly in those with symptomatic CD at diagnosis and in those who present risk factors for fracture such as older age, menopausal status, previous fracture history, and familial hip fracture history. Bone microarchitecture, especially the trabecular network, may be deteriorated, explaining the higher fracture risk in these patients. Adequate calcium and vitamin D supplementation are also recommended to optimize bone recovery, especially during the first years of gluten free diet (GFD). If higher fracture risk persists after 1 or 2 years of GFD, specific osteoactive treatment may be necessary to improve bone health.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Ludvigsson J, Leffler D, Bai JC, Biagi F, Fasano A, Green P, et al. The Oslo definitions for coeliac disease and related terms. Gut. 2013;62:43–52.
Ludvigsson J, Bai JC, Biagi F, Card TR, Ciacci C, Ciclitira PJ, et al. Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut. 2014;63:1210–28.
Pintos Sanchez M, Premysl B, Verdu E, Bai JC. Extraintestinal manifestations of celiac disease. Dig Dis. 2015;33:147–54. Clear summary of all extraintestinal manifestations of celiac disease including bone health.
Green PH, Cellier C. Celiac disease. N Engl J Med. 2007;357(17):1731–43.
Rampertab SD, Pooran N, Brar P, et al. Trends in the presentation of celiac disease. Am J Med. 2006;119:355.e9–e14.
Plugis NM, Khosla C. Therapeutic approaches for celiac disease. Best Pract Res Clin Gastroenterol. 2015;29:503–21.
Corazza G, Di Stefano M, Mauriño E, Bai JC. Bones in coeliac disease: diagnosis and treatment. Best Pract Res Clin Gastroenterol. 2005;19:453–65.
Xing Y, Morgan SL. Celiac disease and metabolic bone disease. J Clin Densitom: Assess Manag Musculoskelet Health. 2013;16(4):439–44.
Fornari C, Pedreira S, Niveloni S, González D, Diez R, Vázquez H, et al. Pre- and post-treatment serum levels of cytokines IL-1β, IL-6, and IL-1 receptor antagonist in celiac disease. Are they related to the associated osteopenia? Am J Gastroenterol. 1998;93(3):413–8.
Sugai E, Cherñasky A, Pedreira S, Smecuol E, Vázquez H, Mazure R, et al. Bone specific antibodies in sera from patients with celiac disease. Characterization and implications in osteoporosis. J Clin Inmmunol. 2002;22:353–62.
Larussa T, Suraci E, Nazionale I, et al. Bone mineralization in celiac disease. Gastroenterol Res Pract 2012:1980–25.
González D, Mazure R, Mautalen C, Vazquez H, Bai JC. Body composition and bone mineral density in untreated and treated patients with celiac disease. Bone. 1995;16:231–4.
Ferretti J, Mazure R, Tanoue P, et al. Analysis of the structure and strength of bones inceliac disease patients. Am J Gastroenterol. 2003;98:382–90.
Duerksen DR, Leslie WD. Longitudinal evaluation of bone mineral density and body composition in patients with positive celiac serology. J Clin Densitom: Assess Skelet Health. 2011;14(4):478–83.
Rios LP, Khan A, Sultan M, McAssey K, Fouda MA, Armstrong D. Canadian. Approach to diagnosing celiac disease in patients with low bone mineral density or fragility fractures. Multidisciplinary task force report. Can Fam Phys. 2013;59:1055–61. Practical and useful clinical guideline for bone approach in CD patients.
Boutroy S, Bouxsein M, Munoz F, Delmas P. In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography. J Clin Endocrinol Metab. 2005;90:6508–15.
Zanchetta MB, Costa F, Longobardi V, Longarini G, Mazure RM, Moreno ML, et al. Significant bone microarchitecture impairment in premenopausal women with active celiac disease. Bone. 2015;76:149–57. First evidence of an important bone microarchitecture impairment in premenopausal women with CD at diagnosis.
Stein EM, Rogers H, Leib A, McMahon DJ, Young P, Nishiyama K, et al. Abnormal skeletal strength and microarchitecture in women with celiac disease. J Clin Endocrinol Metab. 2015;100:2347–53.
Kanis JA, Oden A, Johnell O, De Laet C, Jonsson B, Oglesby AK. The components of excess mortality after hip fracture. Bone. 2003;32(5):468–73.
Vasquez H, Mazure R, Gonzalez D, Flores D, Pedreira S, Niveloni S, et al. Risk of fractures in celiac disease patients: a cross-sectional, case–control study. Am J Gastroenterol. 2000;95:183–9.
Olmos M, Antelo M, Vazquez H, Smecuol E, Mauriño E, Bai JC. Systematic review and meta-analysis of observational studies on the prevalence of fractures in coeliac disease. Dig Liver Dis. 2008;40:46–53.
Heikkilä K, Pearce J, Mäki M, Kaukinen K. Celiac disease and bone fractures: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2015;100(1):25–3.
Moreno ML, Vazquez H, Mazure R, Smecuol E, Niveloni S, Pedreira S, et al. Stratification of bone fracture risk in patients with celiac disease. Clin Gastroenterol Hepatol. 2004;2:127–34.
Pinto Sánchez MI, Mohaidle A, Baistrocchi A, et al. Risk of fracture in celiac disease: gender, dietary compliance, or both? World J Gastroenterol. 2011;17:3035–42.
American Gastroenterological Association. American gastroenterological association medical position statement: guidelines on osteoporosis in gastrointestinal diseases. Gastroenterology. 2003;124:791–4.
Fouda MA, Khan AA, Sultan MS, Rios LP, McAssey K, Armstrong D. Evaluation and management of skeletal health in celiac disease: position statement. Can J Gastroenterol. 2012;26:819–29.
Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Endocrine Society. Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–30.
Edwards MH, Dennison EM, Aihie Sayer A, Fielding R. Cooper C osteoporosis and sarcopenia in older age. Bone. 2015;80:126–30.
Acknowledgments
We thank Susana Carballo for editing the English language of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
María Belén Zanchetta, Vanesa Longobardi, and Julio César Bai declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
All studies by authors involving animal and/or human subjects were performed after approval by the appropriate institutional review boards. When required, written informed consent was obtained from all participants.
Additional information
This article is part of the Topical Collection on Secondary Causes of Osteoporosis
Rights and permissions
About this article
Cite this article
Zanchetta, M.B., Longobardi, V. & Bai, J.C. Bone and Celiac Disease. Curr Osteoporos Rep 14, 43–48 (2016). https://doi.org/10.1007/s11914-016-0304-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11914-016-0304-5